Table 1.
Patient demographic of the study cohort subgroups stratified by biopsy site include primary tumors (Primary), non-lymph node metastases (Met), and lymph node metastases (Lymph)
| Primary | Met | Lymph | Statistic | q-Value | |
|---|---|---|---|---|---|
| Count (N) | 65 | 59 | 14 | ||
| Median age [range] (N) | 27 [6 - 65] (65) | 34 [14 - 82] (59) | 41 [27 - 56] (14) | Kruskal–Wallis | <0.001 |
| Female | 29.2% (19/65) | 13.6% (8/59) | 7.1% (1/14) | Chi-square | 0.042 |
| % Chemo naïve | 92.1% (35/38) | 73.5 (25/34) | 54.5% (6/11) | Chi-square | 0.013 |
| Primary tumor site | |||||
| Ovary | 24.6% (16/65) | 10.2% (6/59) | 7.1% (1/14) | Fisher’s Exact | 0.034 |
| Testicle | 55.4% (36/65) | 74.6% (44/59) | 57.1% (8/14) | ||
| Suprasellar | 3.1% (2/65) | 0.0% (0/59) | 0.0% (0/14) | ||
| Descended testis | 1.5% (1/65) | 1.7% (1/59) | 0.0% (0/14) | ||
| Mediastinum | 7.7% (5/65) | 3.4% (2/59) | 14.3% (2/14) | ||
| Brain, NOS | 4.6% (3/65) | 0.0% (0/59) | 7.1% (1/14) | ||
| Pineal gland | 1.5% (1/65) | 0.0% (0/59) | 0.0% (0/14) | ||
| Pituitary gland | 1.5% (1/65) | 0.0% (0/59) | 0.0% (0/14) | ||
| Misc. | 0.0% (0/65) | 10.1% (6/59) | 14.3% (2/14) | ||